FDA Drug recall D-0217-2017
GlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, Manufactured by: Novo Nordisk A/S 2880 Ba…
- FDA Drug
- Class I
- terminated
- Published 2016-12-28
On 2016-12-28 the FDA classified a Class I recall of GlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, Manufactured by: Novo Nordisk A/S 2880 Ba… by Novo Nordisk, citing defective delivery system: detached needles on the syringe in the kit.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0217-2017 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2016-09-08 |
| Published | 2016-12-28 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Novo Nordisk |
| Distribution | US |
Product
GlucaGen HypoKit (glucagon [rDNA origin] for injection), 1 mg per vial, Single use only, Rx Only, Manufactured by: Novo Nordisk A/S 2880 Bagsvaerd, Denmark, NDC 0169-7065-15
Reason
Defective delivery system: detached needles on the syringe in the kit.
Identifiers
| code_info | Lots: FS6X270, FS6X296, FS6X538, FS6X597, FS6X797, FS6X875; Exp 9/30/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0217-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.